Literature DB >> 15113833

Module-specific antibodies against human connective tissue growth factor: utility for structural and functional analysis of the factor as related to chondrocytes.

Masanao Minato1, Satoshi Kubota, Harumi Kawaki, Takashi Nishida, Akira Miyauchi, Hiroshi Hanagata, Tohru Nakanishi, Teruko Takano-Yamamoto, Masaharu Takigawa.   

Abstract

Connective tissue growth factor/hypertrophic chondrocyte specific gene product 24 (CTGF/Hcs24/CCN2) shows diverse functions in the process of endochondral ossification. It promotes not only the proliferation and differentiation of chondrocytes and osteoblasts in vitro, but also angiogenesis in vivo. The ctgf gene is a member of the gene family called CCN, and it encodes the characteristic 4-module structure of this family, with the protein containing IGFBP, VWC, TSP and CT modules. We raised several monoclonal antibodies and polyclonal antisera against CTGF, and located the epitopes in the modules by Western blotting. For mapping the epitopes, Brevibacillus-produced independent modules were utilized. As a result, at least 1 antibody or antiserum was prepared for the detection of each module in CTGF. Western blotting with these antibodies is expected to be useful for the analysis of CTGF fragmentation. Moreover, we examined the effects of these monoclonal antibodies on the biological functions of CTGF. One out of 3 humanized monoclonal antibodies was found to neutralize efficiently the stimulatory effect of CTGF on chondrocytic cell proliferation. This particular antibody bound to the CT module. In contrast, surprisingly, all of the 3 antibodies recognizing IGFBP, VWC and CT modules stimulated proteoglycan synthesis in chondrocytic cells. Together with previous findings, these results provide insight into the structural-functional relationships of CTGF in executing multiple functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113833     DOI: 10.1093/jb/mvh042

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  CCN family 2/connective tissue growth factor (CCN2/CTGF) promotes osteoclastogenesis via induction of and interaction with dendritic cell-specific transmembrane protein (DC-STAMP).

Authors:  Takashi Nishida; Kenji Emura; Satoshi Kubota; Karen M Lyons; Masaharu Takigawa
Journal:  J Bone Miner Res       Date:  2011-02       Impact factor: 6.741

2.  CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes.

Authors:  Azusa Maeda; Takashi Nishida; Eriko Aoyama; Satoshi Kubota; Karen M Lyons; Takuo Kuboki; Masaharu Takigawa
Journal:  J Biochem       Date:  2008-11-27       Impact factor: 3.387

Review 3.  The pathogenic role of connective tissue growth factor in osteoarthritis.

Authors:  Min Tu; Yao Yao; Feng Hua Qiao; Li Wang
Journal:  Biosci Rep       Date:  2019-07-18       Impact factor: 3.840

4.  Domain-and species-specific monoclonal antibodies recognize the Von Willebrand Factor-C domain of CCN5.

Authors:  Lan Wei; Frank McKeon; Joshua W Russo; Joan Lemire; John Castellot
Journal:  J Cell Commun Signal       Date:  2009-04-29       Impact factor: 5.782

5.  Thrombopoietic-mesenchymal interaction that may facilitate both endochondral ossification and platelet maturation via CCN2.

Authors:  Kumi Sumiyoshi; Satoshi Kubota; Rika A Furuta; Kazuta Yasui; Eriko Aoyama; Harumi Kawaki; Kazumi Kawata; Toshihiro Ohgawara; Takashi Yamashiro; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.